what do glp-1 agonists do How Receptor Evolved from Diabetes to Weight Loss Treatments Part 2 of a 3-Part

A GLP-1 receptor agonist medication may help patients with psoriasis.[ref] Related article: T Cell Exhaustion Asthma symptoms decrease: Asthma exacerbations also decreased in patients on GLP-1 receptor agonist medications.[ref] ( Related article : Asthma genes) Dementia and Alzheimers Prevention: In animal studies, infusions of GLP-1 decrease amyloid-beta levels and prevent neuronal cell death.[ref] Dysregulation of glucose entry into the brain is one hallmark of Alzheimers disease, tying together insulin resistance, GLP-1, and dementia.[ref][ref] GLP-1 receptor agonist drugs, such as liraglutide, are being studied for Alzheimers disease.[ref] Studies using data from diabetes patients showed a significant decrease in dementia for those on GLP-1s vs other diabetes medications

The European Medicines Agency recently recommended authorising liraglutide for weight loss in children under 12, following publication of a year-long randomised trial in 82 children showing a beneficial reduction in BMI

This delayed transit time could reduce pill effectiveness

In markets where there is state/PMI reimbursement of GLP-1 treatment for obesity (eg the US), retatrutide is likely to be reserved as a second-line GLP-1 for those who have failed to lose sufficient weight with a cheaper alternative (such as semaglutide or tirzepatide)

According to its analysis, the gastric emptyingdelaying effect diminishes over time due to the development of tachyphylaxis with prolonged GLP-1 RAs use

Available from Accessed 12 October 2009 18.Heavey S